Search

everythinglearnresearchcommunity

for

Search:↓

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Stopping captopril resolved the skin and hair issues, suggesting it caused them.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Flutamide effectively treats female pattern hair loss long-term with low doses being safe for the liver.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.

Combination therapy is more effective for prostate volumes over 60 ml.

Flutamide and its metabolite can effectively reduce androgen effects.

The document does not give specific results for hair loss treatment effectiveness.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Sabal and Urtica extract works as well as finasteride for treating BPH, with fewer side effects.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

New treatments for skin diseases in 1979 showed promising results with fewer side effects.

Espumil foam base allows easy preparation of skin medications for hairy areas.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Low-dose flutamide effectively maintains reduced hirsutism with no side effects.

Compound 4 is a promising treatment for hair loss with low toxicity.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Finasteride and dutasteride may cause macular abnormalities.

Patients follow treatment well, but many change medicines; good information helps compliance.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.